Clinical Trials Logo

Painful Neuropathy clinical trials

View clinical trials related to Painful Neuropathy.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02758197 Completed - Cancer Clinical Trials

Online MBSR Program for Cancer Survivors With Chronic Neuropathic Pain

COMPASSION
Start date: July 2016
Phase: N/A
Study type: Interventional

This randomized controlled trial will evaluate the effectiveness of an interdisciplinary treatment approach combining medical management with an online Mindfulness-Based Stress Reduction (MBSR) program in reducing disability and improving quality of life among cancer survivors living with moderate to severe chronic neuropathic pain.

NCT ID: NCT02125006 Completed - Breast Cancer Clinical Trials

The Effect of an Inter-Disciplinary Program, Including MBSR, in Breast Cancer Survivors With Chronic Neuropathic Pain

InDepth
Start date: October 2013
Phase: N/A
Study type: Interventional

Chronic neuropathic pain is a common problem for breast cancer survivors. Even with the best medical treatment, some survivors continue to experience disabling pain. It is well-established that an interdisciplinary approach is key to the treatment of some types of chronic pain, but little research has been done on the effectiveness of interdisciplinary treatments for cancer survivors with chronic neuropathic pain. The investigators will evaluate the effectiveness of an interdisciplinary approach combining medical treatment and mindfulness-based stress reduction (MBSR) to reduce disability and improve quality of life among breast cancer survivors with chronic neuropathic pain. The investigators will also evaluate the impact of the program on psychological distress, pain cognitions, biomarkers of stress and immune function, cognitive function, as well as brain structure and function.

NCT ID: NCT01363284 Completed - Diabetes Clinical Trials

Pretreatment Identification of Duloxetine Success in Neuropathic Pain Patients

Start date: June 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to identify, prior to prescribing, which neuropathic pain patients will benefit from duloxetine more specific the investigators aims are to: - Verify whether presence of chronic pain alters the pain modulation mechanisms, such as DNIC (diffuse noxious inhibitory control) and TS (temporal summation). - Investigate whether anti-neuropathic medications such as duloxetine indeed change the pain modulation profile, and whether this profile change is associated with a reduction of clinical pain.